• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . End-to-end antigenic variant generation for H1N1 influenza HA protein using sequence to sequence models

tetano

Editor, Senior Moderator
PLoS One


. 2022 Mar 28;17(3):e0266198.
doi: 10.1371/journal.pone.0266198. eCollection 2022.
End-to-end antigenic variant generation for H1N1 influenza HA protein using sequence to sequence models


Mohamed Elsayed Abbas[SUP] 1 2 [/SUP], Zhu Chengzhang[SUP] 1 3 2 [/SUP], Ahmed Fathalla[SUP] 4 [/SUP], Yalong Xiao[SUP] 1 3 [/SUP]



Affiliations
Free article

Abstract

The growing risk of new variants of the influenza A virus is the most significant to public health. The risk imposed from new variants may have been lethal, as witnessed in the year 2009. Even though the improvement in predicting antigenicity of influenza viruses has rapidly progressed, few studies employed deep learning methodologies. The most recent literature mostly relied on classification techniques, while a model that generates the HA protein of the antigenic variant is not developed. However, the antigenic pair of influenza virus A can be determined in a laboratory setup, the process needs a tremendous amount of time and labor. Antigenic shift and drift which are caused by changes in surface protein favored the influenza A virus in evading immunity. The high frequency of the minor changes in the surface protein poses a challenge to identifying the antigenic variant of an emerging virus. These changes slow down vaccine selection and the manufacturing process. In this vein, the proposed model could help save the time and efforts exerted to identify the antigenic pair of the influenza virus. The proposed model utilized an end-to-end learning methodology relying on deep sequence-to-sequence architecture to generate the antigenic variant of a given influenza A virus using surface protein. Employing the BLEU score to evaluate the generated HA protein of the antigenic variant of influenza virus A against the actual variant, the proposed model achieved a mean accuracy of 97.57%.
 
Back
Top Bottom